# Study to Compare 2 Botulinum Type A Toxins in the Treatment of Glabellar Frown Lines

> **NCT04763265** · PHASE2 · COMPLETED · sponsor: **Croma-Pharma GmbH** · enrollment: 208 (actual)

## Conditions studied

- Frown Lines

## Interventions

- **BIOLOGICAL:** Botulinum toxin A "BoNT/A-DP"
- **BIOLOGICAL:** Botulinum toxin A "Botox Cosmetics"

## Key facts

- **NCT ID:** NCT04763265
- **Lead sponsor:** Croma-Pharma GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-24
- **Primary completion:** 2020-11-05
- **Final completion:** 2021-02-01
- **Target enrollment:** 208 (ACTUAL)
- **Last updated:** 2025-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04763265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04763265, "Study to Compare 2 Botulinum Type A Toxins in the Treatment of Glabellar Frown Lines". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04763265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*